Follow Us

scroll

scroll-down

Lead Program

pipeline-pic

 

Gain’s lead drug candidate is a best-in-class small molecule, for the treatment of GBA-Parkinson’s disease and other neurodegenerative diseases. is currently being evaluated in a Phase I clinical study.

 

Lead Program >>